Abstract
Objective: To highlight the association between the use of clozapine and the early development of severe mixed hyperlipidemia, a condition that substantially increases the risk of cardiovascular events and other medical complications.Method: Clinical information and data from investigations in a single patient were collated and reviewed in light of the literature. Results: A 47-year-old mail with a background history of schizophrenia taking clozapine presented with multiple episodes of severe elevation of serum triglycerides and cholesterol with subsequent development of diabetes mellitus. His metabolic parameters normalized following discontinuation of clozapine.Conclusion: Lipid and metabolic profiles should be closely monitored in patients receiving clozapine in order to facilitate early detection and intervention to prevent further health complications. (C) 2009 Elsevier Inc. All rights reserved.
| Original language | English (Ireland) |
|---|---|
| Pages (from-to) | 93-96 |
| Number of pages | 4 |
| Journal | General Hospital Psychiatry |
| Volume | 31 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 1 Jan 2009 |
Keywords
- Clozapine
- Hypertriglyceridemia
- Severe mixed hyperlipidemia
Authors (Note for portal: view the doc link for the full list of authors)
- Authors
- Ahmed, M,Griffin, D,O'Toole, R,McDonald, C
